Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma

By Lyseng-Williamson Katherine A.   Yang Lily P.H.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite

Therapeutic Advances in Biological Response Modifiers in the Treatment of Cutaneous T-Cell Lymphoma

By Vittorio C.C.   Rook A.H.   French L.E.   Shapiro M.   Lehrer M.S.   Junkinshopkins J.M.  

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 431-437

Adis International

Access to resources Recommend Favorite

Skin lesions and neutrophilic leukemoid reaction in a patient with angioimmunoblastic T‐cell lymphoma: a case report and review of the literature

By  

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma†: Profile Report

By Hoy Sheridan M.   McKeage Kate  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 193-195

Adis International

Access to resources Recommend Favorite

Treatment of Cutaneous T Cell Lymphoma: Current Status and Future Directions

By Apisarnthanarax N.   Talpur R.   Duvic M.  

American Journal of Clinical Dermatology, Vol. 3, Iss. 3, 2002-03 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite